Co-beneldopa (Benserazide/levodopa) Prescribing at MIDDLEWOOD PARTNERSHIP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
649
Total Quantity
95.2K
NHS Cost
£6.2K
vs National Avg
+329.3%
MIDDLEWOOD PARTNERSHIP prescribed 649 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £6,225 to the NHS. This is 329.3% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
56
Jul 2026
50
Jul 2026
58
Jul 2026
50
Jul 2026
46
Jul 2026
55
Jul 2026
55
Jul 2026
46
Jul 2026
58
Jul 2026
60
Jul 2026
53
Jul 2026
62
Prescribing Details
| Total Items | 649 |
|---|---|
| Total Quantity | 95,200 |
| Total NHS Cost | £6,225 |
| Presentations | 11 different forms |
| vs National Average | +329.3% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 649 items |
|---|---|
| National average per practice | 151 items |
| Difference | +329.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.